World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23864
World Ranking
17518
National Ranking
1586

Overview

Anthony V. Moorman is affiliated with Newcastle University in the United Kingdom. Their research focuses primarily on Medicine, with significant contributions in the subfields of Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, Oncology, and Molecular Biology.

The scientist's work centers on topics including Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research, Cancer Genomics and Diagnostics, and Chronic Lymphocytic Leukemia Research.

Recent papers authored or co-authored by Anthony V. Moorman include:

  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL, 2021, published in Blood
  • Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia, 2023, published in Leukemia
  • Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study, 2020, published in The Lancet Haematology
  • Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group, 2021, published in Leukemia
  • Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials, 2021, published in the European Journal of Cancer

Their frequent co-authors include:

  • Ajay Vora (36 publications)
  • Christine J. Harrison (26 publications)
  • Amir Enshaei (23 publications)
  • Adele K. Fielding (17 publications)
  • Amy A. Kirkwood (16 publications)

Anthony V. Moorman has published extensively in several key venues:

  • Blood (23 publications)
  • Leukemia (15 publications)
  • HemaSphere (6 publications)
  • Journal of Clinical Oncology (5 publications)
  • Blood Advances (5 publications)

Best Publications

  • Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    David Grimwade;Robert K. Hills;Anthony V. Moorman;Helen Walker

  • Genetic variegation of clonal architecture and propagating cells in leukaemia

    Kristina Anderson;Christoph Lutz;Frederik W. van Delft;Caroline M. Bateman

  • Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: A meta-analysis of individual patient data from randomised controlled trials

    Robert Kerrin Hills;Sylvie Castaigne;Frederick R. Appelbaum;Jacques Delaunay

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

    Lisa J. Russell;Melania Capasso;Inga Vater;Takashi Akasaka

  • Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

    Anthony V Moorman;Hannah M Ensor;Sue M Richards;Lucy Chilton

  • T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

    David I. Marks;Elisabeth M. Paietta;Anthony V. Moorman;Susan M. Richards

  • UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

    Adele K. Fielding;Jacob M. Rowe;Georgina Buck;Letizia Foroni

  • Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

    Chirstine J. Harrison;Robert Kerrin Hills;Anthony V. Moorman;David J. Grimwade

  • The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Thomas B. Alexander;Thomas B. Alexander;Zhaohui Gu;Ilaria Iacobucci;Kirsten Dickerson

  • Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

    Catriona Parker;Rachel Waters;Carly Leighton;Carly Leighton;Jeremy Hancock

  • Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: Results from the International ALL Trial MRC UKALLXII/ECOG2993

    Adele K. Fielding;Jacob M. Rowe;Susan M. Richards;Georgina Buck

  • Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

    Ajay Vora;Nick Goulden;Chris Mitchell;Jeremy Hancock

  • Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia

    James M. Allan;Christopher P. Wild;Sara Rollinson;Eleanor V. Willett

  • RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

    David T. Bowen;Marion E. Frew;Robert Kerrin Hills;Rosemary E. Gale

  • PROGNOSTIC FACTOR ANALYSIS OF THE SURVIVAL OF ELDERLY PATIENTS WITH AML IN THE MRC AML11 AND LRF AML14 TRIALS

    Keith Wheatley;Cassandra l. Brookes;Andrew J. Howman;Anthony H. Goldstone

  • Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

    Amy L. Sherborne;Fay J. Hosking;Rashmi B. Prasad;Rajiv Kumar

  • Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

    Yilong Li;Claire Schwab;Sarra L. Ryan;Elli Papaemmanuil

  • Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

    Trudy D. Buitenkamp;Shai Izraeli;Martin Zimmermann;Erik Forestier

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Christine J. Harrison
Christine J. Harrison Newcastle University
Charles G. Mullighan
Charles G. Mullighan St. Jude Children's Research Hospital
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Martin Schrappe
Martin Schrappe Kiel University
Eve Roman
Eve Roman University of York
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
David I. Marks
David I. Marks University Hospitals Bristol NHS Foundation Trust
Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in a healthcare career or seeking to expand their medical qualifications in the USA, online nursing and advanced practice degrees provide flexible and accelerated options. Fast-track programs are highly sought after by working professionals aiming to quickly progress in their careers. For example, completing a 6 month lpn program can help individuals launch their nursing career in less than a year, saving both time and tuition.

Nurses with an MSN who want to advance further might consider the fastest msn to dnp program available online. These programs are designed for efficiency, allowing students to become doctorally prepared nurses in a shorter duration. For those who prefer a less research-intensive pathway, there are also online dnp programs without dissertation, which eliminate the need for a traditional lengthy dissertation and focus more on clinical skills and leadership.

Furthermore, mental health is a growing field in medical care. Qualified nurses can specialize further with online psych np programs, gaining expertise to support patients with psychiatric needs. These diverse online degree options offer efficient and accessible routes to rewarding healthcare careers.

Best Scientists Citing Anthony V. Moorman

Trending Scientists